Study S001147

An Investigator-Initiated, Randomized, Open-Label, Active-Controlled Study Comparing the Effects of BGM0504 Injection Versus Semaglutide Injection on Insulin Sensitivity and Body Weight in Obese Subjects

ClinicalTrials.gov record

Registration

Registration: NCT07836140
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 60
Start: 2024-04-22
Primary completion: 2025-04-25
Lead sponsor: Second Affiliated Hospital of Soochow University
Conditions: Obesity / Overweight
Interventions: DRUG:semaglutide; DRUG:BGM0504 Administered SC
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

HOMA2-β index [Target dose at week 16]
HOMA2-IR [Target dose at week 16]
MFI [Target dose at week 16]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.